Search Results - "Kreidlova, Miluse"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Therapy of chronic hepatitis C in people who inject drugs: focus on adherence by Frankova, Sona, Jandova, Zuzana, Jinochova, Gabriela, Kreidlova, Miluse, Merta, Dusan, Sperl, Jan

    Published in Harm reduction journal (30-06-2021)
    “…Abstract Background Intravenous drug use (IVDU) represents the major factor of HCV transmission, but the treatment uptake among people who inject drugs (PWID)…”
    Get full text
    Journal Article
  2. 2

    PNPLA3 rs738409 G allele carriers with genotype 1b HCV cirrhosis have lower viral load but develop liver failure at younger age by Senkerikova, Renata, Frankova, Sona, Jirsa, Milan, Kreidlova, Miluse, Merta, Dusan, Neroldova, Magdalena, Chmelova, Klara, Spicak, Julius, Sperl, Jan

    Published in PloS one (17-09-2019)
    “…PNPLA3 rs738409 minor allele c.444G represents a risk factor for liver steatosis and fibrosis progression also in chronic hepatitis C (HCV). We investigated…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Long‐term outcomes and reverse remodelling in recently diagnosed unexplained left ventricular systolic dysfunction by Kuchynka, Petr, Podzimkova, Jana, Marek, Josef, Danek, Barbara Anna, Vitkova, Ivana, Kreidlova, Miluse, Roblova, Lenka, Kovarnik, Tomas, Simek, Stanislav, Horak, Jan, Habasko, Jan, Linhart, Ales, Palecek, Tomas

    Published in ESC Heart Failure (01-04-2024)
    “…Aims In patients with recently diagnosed non‐ischaemic LV systolic dysfunction, left ventricular reverse remodelling (LVRR) and favourable prognosis has been…”
    Get full text
    Journal Article
  5. 5

    Expression of Biliverdin Reductase A in peripheral blood leukocytes is associated with treatment response in HCV-infected patients by Subhanova, Iva, Muchova, Lucie, Lenicek, Martin, Vreman, Hendrik J, Luksan, Ondrej, Kubickova, Kristyna, Kreidlova, Miluse, Zima, Tomas, Vitek, Libor, Urbanek, Petr

    Published in PloS one (11-03-2013)
    “…Hepatitis C virus (HCV) infection is associated with systemic oxidative stress. Since the heme catabolic pathway plays an important role in antioxidant…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Combination of sofosbuvir and daclatasvir in the treatment of genotype 3 chronic hepatitis C virus infection in patients on maintenance hemodialysis by Sperl, Jan, Frankova, Sona, Kreidlova, Miluse, Merta, Dusan, Tothova, Monika, Spicak, Julius

    Published in Therapeutics and clinical risk management (01-01-2017)
    “…Chronic hepatitis C virus infection (HCV) has a negative impact on the long-term survival of recipients of kidney transplants. HCV should be treated in…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Expression of Biliverdin Reductase A in Peripheral Blood Leukocytes Is Associated with Treatment Response in HCV-Infected Patients. e57555 by Subhanova, Iva, Muchova, Lucie, Lenicek, Martin, Vreman, Hendrik J, Luksan, Ondrej, Kubickova, Kristyna, Kreidlova, Miluse, Zima, Tomas, Vitek, Libor, Urbanek, Petr

    Published in PloS one (01-03-2013)
    “…Background and Aims Hepatitis C virus (HCV) infection is associated with systemic oxidative stress. Since the heme catabolic pathway plays an important role in…”
    Get full text
    Journal Article